Nicotine treatment and smoking cessation in the era of COVID-19 pandemic: an interesting alliance

Afroditi K. Boutou, Georgia Pitsiou, Theodore Kontakiotis, Ioannis Kioumis

Source: ERJ Open Res, 6 (3) 00306-2020; 10.1183/23120541.00306-2020
Journal Issue: July

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Afroditi K. Boutou, Georgia Pitsiou, Theodore Kontakiotis, Ioannis Kioumis. Nicotine treatment and smoking cessation in the era of COVID-19 pandemic: an interesting alliance. ERJ Open Res, 6 (3) 00306-2020; 10.1183/23120541.00306-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nicotine vaccination for smoking cessation: is it effective and safe?
Source: International Congress 2015 – New advances in smoking cessation interventions
Year: 2015



Electronic cigarettes for smoking cessation: an opportunity to readdress smoking cessation treatment
Source: Eur Respir J, 56 (4) 2000098; 10.1183/13993003.00098-2020
Year: 2020



Nicotine and cannabis use among teenagers: from prevention to treatment. What works?
Source: Virtual Congress 2021 – Orphan childhood disease: nicotine and cannabis addiction
Year: 2021


Bupropion together with cognitive-conductual therapy (CBT) is an alternative for a long-term abstinence of smoking
Source: Annual Congress 2013 –Smoking cessation for healthy and non-healthy smokers
Year: 2013


Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?
Source: Eur Respir J 2009; 33: 468-480
Year: 2009



Smoking cessation according to nicotine dependence: experience of a smoking cessation program
Source: Virtual Congress 2020 – From tobacco control policy to smoking cessation
Year: 2020


Cytisine is an effective smoking cessation medication: more evidence now than ever before
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017

Smoking cessation success according to anxiety levels: experience of a smoking cessation program
Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Year: 2019

Nonpharmacological smoking cessation interventions in clinical practice
Source: Eur Respir Rev 2008; 17: 187-191
Year: 2008



Smoking cessation using innovative techniques: course report
Source: Breathe 2015; 11: 255-256
Year: 2015


Barriers to smoking cessation: the patient’s perspective
Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Year: 2019

Smoking cessation: can we obtain more than we do at present?
Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke?
Year: 2006


Smoking cessation: a clinical update
Source: Eur Respir Rev 2008; 17: 171
Year: 2008


Smoking cessation with bupropion - is it successful enough?
Source: Eur Respir J 2005; 26: Suppl. 49, 388s
Year: 2005

Relapse rates following different types of medication treatment through a smoking cessation program
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006


Pharmacological treatment for smoking cessation
Source: Eur Respir Mon; 2008: 42: 74–97
Year: 2008